A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

Parkinson’s disease (PD) is diagnosed when motor symptoms emerges, which almost 70% of dopamine neurons are lost. Therefore, early diagnosis of PD is crucial to prevent the progress of disease. Blood-based biomarkers, which are minimally invasive, potentially used for diagnosis of PD, including miRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazeli, Soudabeh, Motovali-Bashi, Majid, Peymani, Maryam, Hashemi, Motahare-Sadat, Etemadifar, Masoud, Nasr-Esfahani, Mohammad Hossein, Ghaedi, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654768/
https://www.ncbi.nlm.nih.gov/pubmed/33171483
http://dx.doi.org/10.1371/journal.pone.0240855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654768/
https://www.ncbi.nlm.nih.gov/pubmed/33171483
http://dx.doi.org/10.1371/journal.pone.0240855

Ejemplares similares